Fig. 1From: FDG-PET parameters predict for recurrence in anal cancer – results from a prospective, multicentre clinical trialPre- (a) and post- (b) chemo-radiotherapy FDG-PET/CT of a patient who did not experience a local recurrence. Pre- (c) and post- (d) chemo-radiotherapy FDG-PET/CT of a patient who subsequently experienced a local recurrenceBack to article page